Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2003

01-04-2003 | Case Report

Cytotoxic T-Cell Lymphoma Arising in Behçet Disease

Authors: Yukitaka Katsura, Kazumi Suzukawa, Hiroshi Kojima, Chikashi Yoshida, Seiichi Shimizu, Harumi Mukai, Yuichi Hasegawa, Shigehiko Imagawa, Naoyoshi Mori, Toshiro Nagasawa

Published in: International Journal of Hematology | Issue 3/2003

Login to get access
Metadata
Title
Cytotoxic T-Cell Lymphoma Arising in Behçet Disease
Authors
Yukitaka Katsura
Kazumi Suzukawa
Hiroshi Kojima
Chikashi Yoshida
Seiichi Shimizu
Harumi Mukai
Yuichi Hasegawa
Shigehiko Imagawa
Naoyoshi Mori
Toshiro Nagasawa
Publication date
01-04-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983787

Other articles of this Issue 3/2003

International Journal of Hematology 3/2003 Go to the issue

OriginalPaper

In vivo Platelet Activation and Hyperaggregation in Hemoglobin E/β-Thalassemia: A Consequence of Splenectomy

OriginalPaper

Global Gene Expression Profiling in the Study of Multiple Myeloma

OriginalPaper

Serum Immunoglobulin Levels at Onset: Association with the Prognosis of Childhood Idiopathic Thrombocytopenic Purpura

Case Report

Hemophagocytic Syndrome Associated with Severe Adenoviral Pneumonia: Usefulness of Real-Time Polymerase Chain Reaction for Diagnosis

OriginalPaper

The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas

Letter to the Editor

Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits